From: Acceptance of oral chemotherapy in breast cancer patients - a survey study
Question No. | Therapyform | N evaluable patients | 1 not at all | 2 | 3 | 4 very much | p-value |
---|---|---|---|---|---|---|---|
1 | i.v. | 161 | 22.98 | 22.36 | 26.09 | 28.57 | <0.0001 |
 | p.o. | 60 | 3.33 | 5.00 | 33.33 | 58.33 |  |
2 | i.v. | 162 | 35.80 | 38.27 | 20.37 | 5.56 | <0.0001 |
 | p.o. | 60 | 16.67 | 18.33 | 36.67 | 28.33 |  |
3 | i.v. | 163 | 65.03 | 17.18 | 10.43 | 7.36 | 0.0757 |
 | p.o. | 60 | 80.00 | 11.67 | 8.33 | 0.00 |  |
4 | i.v. | 164 | 23.17 | 20.12 | 32.32 | 24.39 | 0.0074 |
 | p.o. | 60 | 8.33 | 10.00 | 45.00 | 36.67 |  |
5 | i.v. | 155 | 7.10 | 29.68 | 43.87 | 19.35 | <0.0001 |
 | p.o. | 57 | 1.75 | 5.26 | 43.86 | 49.12 |  |
6 | i.v. | 160 | 40.63 | 40.63 | 13.13 | 5.63 | <0.0001 |
 | p.o. | 59 | 22.03 | 25.42 | 27.12 | 25.42 |  |
7 | i.v. | 161 | 21.12 | 20.50 | 39.75 | 18.63 | 0.5605 |
 | p.o. | 56 | 16.07 | 21.43 | 35.71 | 26.79 |  |
8 | i.v. | 163 | 36.81 | 26.99 | 22.09 | 14.11 | <0.0001 |
 | p.o. | 59 | 8.47 | 23.73 | 35.59 | 32.20 |  |
9 | i.v. | 164 | 23.78 | 23.17 | 28.05 | 25.00 | 0.0005 |
 | p.o. | 58 | 6.90 | 10.34 | 34.48 | 48.28 |  |